Communications medicineJul 30, 2026

Safety, practicality, and early results of psilocybin therapy for veterans with severe, hard-to-treat PTSD

Psychedelic Science Weekly Brief ↗PubMed ↗DOI ↗OA ↗

Updated Aug 3, 2026

Abstract

Psilocybin-assisted therapy (PAT) may be a potential treatment for PTSD in U.S. military Veterans.

PTSD is more severe in military Veterans compared to the general population.
Veterans face increased risks of suicide associated with PTSD.
Preliminary findings suggest PAT could benefit individuals with PTSD.
Further research is needed to assess the safety and effectiveness of PAT in this population.

Simplified

Full Text

Full text is available at the source.

View Full Text ↗

Featured in

Psychedelic Science

Psychedelic ScienceIssue #49

Psilocybin stays active in neurons long after it leaves the bloodstream — here's what that means

Weekly Psychedelic Science Brief

You found one interesting study. We’ll send the next 7.

Get 7 new psychedelic science papers each week, explained in plain English with direct links to the originals.

What Lands in Your Inbox Each Week:

📚7 fresh studies
📝plain-language summaries
✅direct links to original studies
🏅top journal indicators
📅weekly delivery
🧘‍♂️always free

Recent issues from the psychedelic science brief

Psilocybin stays active in neurons long after it leaves the bloodstream — here's what that means

Psychedelics during adolescence reshaped adult social behavior in rats — here's the circuit

1 week ago7 studies

Psilocybin rewired prefrontal circuits in mice — but only for one specific type of cognitive failure

2 weeks ago7 studies

Psilocybin cut two specific brain chemicals in depressed patients — here's what that means

3 weeks ago7 studies

Psilocybin rewires brain feedback circuits for weeks after a single dose, new evidence shows

4 weeks ago7 studies

A pill form of ketamine cut dissociation to near-zero vs. nasal spray's 29.6-point spike — but missed its main antidepressant target

5 weeks ago7 studies

At-home ketamine injections cut depression scores by more than half in 3,870 patients

6 weeks ago8 studies

Psychedelics disrupt brain signal flow in both humans and mice across LSD, psilocybin, and MDMA

7 weeks ago7 studies

Inhaled 5-MeO-DMT cut postpartum depression scores by 35 points

8 weeks ago7 studies

Psilocybin's antidepressant effects lasted 12 months in 126 treatment-resistant patients

9 weeks ago7 studies

explore the archive

See more issues from the psychedelic science brief